180 related articles for article (PubMed ID: 4091865)
1. [Synthesis and positive inotropic action of some 5-substituted 5H-(1)benzopyrano(4,3-b)pyridines].
Heber D; Ravens U
Arzneimittelforschung; 1985; 35(11):1624-6. PubMed ID: 4091865
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
Heber D; Ravens U; Schulze T
Pharmazie; 1993 Jul; 48(7):509-13. PubMed ID: 8415847
[TBL] [Abstract][Full Text] [Related]
3. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
[TBL] [Abstract][Full Text] [Related]
4. [Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines].
Roloff B; Schäfer J; Rumler A; Hagen V; Hagen A
Pharmazie; 1989 Dec; 44(12):859-60. PubMed ID: 2635323
[No Abstract] [Full Text] [Related]
5. [Potential cardiotonic agents. 10. Synthesis and positive inotropic action of 5-(4-pyridinyl)- and 5-phenyl-substituted 2-alkylthio-3-cyan-pyridines and their S-oxidation products].
Rumler A; Hagen V; Hagen A
Pharmazie; 1990 Sep; 45(9):657-9. PubMed ID: 2284307
[TBL] [Abstract][Full Text] [Related]
6. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
Pharmazie; 1989 Jan; 44(1):20-3. PubMed ID: 2727022
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis of 5H [1]benzopyrano[2,3-b] pyridine derivatives].
Nantka-Namirski P; Piechaczek J; Wrotek J
Acta Pol Pharm; 1977; 34(1):1-7. PubMed ID: 848310
[No Abstract] [Full Text] [Related]
8. [Synthesis and cardiotonic activity of pyrazolylpyrimidines].
Sedereviciute V; Garaliene V; Vainilavicius P; Hetzheim A
Pharmazie; 1998 Apr; 53(4):233-7. PubMed ID: 9583084
[TBL] [Abstract][Full Text] [Related]
9. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
[TBL] [Abstract][Full Text] [Related]
10. [Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones].
Hagen V; Rumler A; Reck G; Hagen A; Labes D; Heer S
Pharmazie; 1989 Dec; 44(12):809-13. PubMed ID: 2635317
[TBL] [Abstract][Full Text] [Related]
11. [Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine].
Hagen V; Klauschenz E; Rumler A; Niedrich H; Hagen A; Heer S; Mitzner R
Pharmazie; 1990 May; 45(5):343-5. PubMed ID: 2395896
[TBL] [Abstract][Full Text] [Related]
12. In vivo cardiotonic activity of pyridylmethylene-2-indolinones.
Andreani A; Locatelli A; Morigi R; Leoni A; Bossa R; Chiericozzi M; Galatulas I
Arzneimittelforschung; 1998 Jul; 48(7):727-9. PubMed ID: 9706372
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis of 3-substituted 6-methyl-4-pyridyl-2 (1H) pyridones and testing of their cardiovascular action].
Hanfeld V; Leistner S; Wagner G; Lohmann D; Poppe H; Heer S
Pharmazie; 1988 Oct; 43(10):677-9. PubMed ID: 3212010
[TBL] [Abstract][Full Text] [Related]
14. A novel positive inotropic series. 1st communication: in vitro studies of 3-, 4-, 5-, 6-, 7- and 8-pyridyl-2(1H)-quinolone derivatives.
Decker N; Grima M; Velly J; Marciniak G; Leclerc G; Schwartz J
Arzneimittelforschung; 1987 Oct; 37(10):1108-12. PubMed ID: 2829930
[TBL] [Abstract][Full Text] [Related]
15. N-aralkyl substitution of 2-aminoindans. Synthesis and their inotropic and chronotropic activity in isolated guinea pig atria.
Pérez JA; Domínguez JN; Angel JE; Duerto de Pérez Z; Salazar-Bookaman MM; Acosta H; Charris JE
Arzneimittelforschung; 1997 Nov; 47(11):1208-10. PubMed ID: 9428975
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cardiotonic activity of certain imidazo[2,1-b]-1,3,4-thiadiazole derivatives.
el-Sherbeny MA; el-Bendary ER; el-Subbagh HI; el-Kashef HA
Boll Chim Farm; 1997 Mar; 136(3):253-6. PubMed ID: 9164165
[TBL] [Abstract][Full Text] [Related]
17. [Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines].
Klauschenz E; Rumler A; Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
Pharmazie; 1989 Jan; 44(1):23-5. PubMed ID: 2727023
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of action by which 5H-[1]-benzopyrano-[2,3,-b]-pyridin-5-ol (AH 6696) inhibits gastric acid secretion [proceedings].
Ashby P; Curwain BP; Daly MJ; McIsaac RL
Br J Pharmacol; 1976 Jul; 57(3):440P-441P. PubMed ID: 974337
[No Abstract] [Full Text] [Related]
19. Coronary vasodilation and positive inotropic effect of non steroidal cardiotonics.
Decker N; Grima M; Schwartz J
J Pharmacol; 1985; 16(4):391-402. PubMed ID: 4094436
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of new esters of 2- and 4-alkylamino-1,8-naphthyridine-3-carboxylic acids endowed with positive inotropic properties.
Heber D; Verborg M; Mohr K
Arzneimittelforschung; 1994 Jul; 44(7):809-14. PubMed ID: 7945513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
